Standard BioTools Balance Sheet Health
Financial Health criteria checks 5/6
Standard BioTools has a total shareholder equity of $577.3M and total debt of $55.0M, which brings its debt-to-equity ratio to 9.5%. Its total assets and total liabilities are $777.7M and $200.4M respectively.
Key information
9.5%
Debt to equity ratio
US$54.96m
Debt
Interest coverage ratio | n/a |
Cash | US$462.28m |
Equity | US$577.32m |
Total liabilities | US$200.35m |
Total assets | US$777.67m |
Recent financial health updates
Health Check: How Prudently Does Standard BioTools (NASDAQ:LAB) Use Debt?
Jan 12Is Standard BioTools (NASDAQ:LAB) A Risky Investment?
Aug 13Does Fluidigm (NASDAQ:FLDM) Have A Healthy Balance Sheet?
Dec 15Is Fluidigm (NASDAQ:FLDM) A Risky Investment?
Jul 27Recent updates
Is It Time To Consider Buying Standard BioTools Inc. (NASDAQ:LAB)?
Apr 09Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)
Mar 06Standard BioTools Inc.'s (NASDAQ:LAB) P/S Still Appears To Be Reasonable
Feb 17Health Check: How Prudently Does Standard BioTools (NASDAQ:LAB) Use Debt?
Jan 12Is Standard BioTools (NASDAQ:LAB) A Risky Investment?
Aug 13Fluidigm Corporation: Investment Opportunity
Jan 26Does Fluidigm (NASDAQ:FLDM) Have A Healthy Balance Sheet?
Dec 15Is Fluidigm (NASDAQ:FLDM) A Risky Investment?
Jul 27Fluidigm Corporation: Discounted Life Sciences Instrument Developer Offers Compelling Entry Point
Jun 20Fluidigm gains after report that activist takes 11% stake, may push for unit sale
May 11Fluidigm Corporation 2021 Q1 - Results - Earnings Call Presentation
May 07Financial Position Analysis
Short Term Liabilities: LAB's short term assets ($547.6M) exceed its short term liabilities ($121.6M).
Long Term Liabilities: LAB's short term assets ($547.6M) exceed its long term liabilities ($78.8M).
Debt to Equity History and Analysis
Debt Level: LAB has more cash than its total debt.
Reducing Debt: LAB's debt to equity ratio has reduced from 27.3% to 9.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LAB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LAB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.